BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27803964)

  • 1. Adrenal crisis while on high-dose steroid treatment: what rheumatologist should consider?
    Üsküdar Cansu D; Cansu GB; Arik D; Korkmaz C
    Rheumatol Int; 2017 Apr; 37(4):657-662. PubMed ID: 27803964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of epidural methylprednisolone acetate injection on the hypothalamic-pituitary-adrenal axis.
    Habib G; Jabbour A; Salman J; Hakim G; Haddad H
    J Clin Anesth; 2013 Dec; 25(8):629-33. PubMed ID: 23988802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of a Post-Operative Addisonian Crisis from HPA Axis Suppression from Inhaled Corticosteroids.
    Allen G; Mitchell A; Ramirez M; Holsten S; Shah N
    Am Surg; 2019 Sep; 85(9):e483-e484. PubMed ID: 31638547
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid therapy and adrenal function].
    Cota D; Ceroni L; Pasquali R
    Recenti Prog Med; 2000 Nov; 91(11):594-600. PubMed ID: 11125954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases.
    Huber BM; Bolt IB; Sauvain MJ; Flück CE
    Acta Paediatr; 2010 Dec; 99(12):1889-93. PubMed ID: 20649769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression.
    Levin E; Gupta R; Butler D; Chiang C; Koo JY
    J Dermatolog Treat; 2014 Dec; 25(6):501-6. PubMed ID: 24171390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
    Vollenweider P; Waeber G
    Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler.
    Kennedy MJ; Carpenter JM; Lozano RA; Castile RG
    Ann Allergy Asthma Immunol; 2002 May; 88(5):523-6. PubMed ID: 12027076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturday conference: steroid withdrawal syndromes.
    Sullivan JN
    South Med J; 1982 Jun; 75(6):726-33. PubMed ID: 7046066
    [No Abstract]   [Full Text] [Related]  

  • 12. [Control of the hypothalamic-hypophyseal-adrenal cortex regulatory zone with ACTH and the metopirone test in long-term glucocorticoid therapy].
    Saitmacher F
    Dtsch Gesundheitsw; 1970 Dec; 25(49):2334-8. PubMed ID: 4324036
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged Steroid Dependence in Adult Patients With Glioma.
    Mantilla EC; Abramowitz J; Dan TU; Pan E
    Anticancer Res; 2020 Apr; 40(4):2059-2064. PubMed ID: 32234897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged adrenal insufficiency after high-dose glucocorticoid in infants with leukemia.
    Moritani K; Tauchi H; Ochi F; Yonezawa S; Takemoto K; Eguchi-Ishimae M; Eguchi M; Ishii E; Nagai K
    Pediatr Hematol Oncol; 2018; 35(5-6):355-361. PubMed ID: 30457427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased risk of adrenal cortex failure after treatment of allergic rhinitis].
    Rolandsson O
    Lakartidningen; 1996 Jul; 93(28-29):2564. PubMed ID: 8801405
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective observational study evaluating hypothalamic-pituitary-adrenal axis alteration and efficacy of intramuscular triamcinolone acetonide for steroid-responsive dermatologic disease.
    Reddy S; Ananthakrishnan S; Garg A
    J Am Acad Dermatol; 2013 Aug; 69(2):226-31. PubMed ID: 23545370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal Insufficiency Caused by Locally Applied Glucocorticoids-Myth or Fact?
    Borresen SW; Klose M; Rasmussen AK; Feldt-Rasmussen U
    Curr Med Chem; 2015; 22(23):2801-9. PubMed ID: 26180005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself.
    Dinsen S; Baslund B; Klose M; Rasmussen AK; Friis-Hansen L; Hilsted L; Feldt-Rasmussen U
    Eur J Intern Med; 2013 Dec; 24(8):714-20. PubMed ID: 23806261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment.
    Sagar R; Mackie S; W Morgan A; Stewart P; Abbas A
    Clin Endocrinol (Oxf); 2021 Mar; 94(3):361-370. PubMed ID: 33370485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythms in rheumatology--a glucocorticoid perspective.
    Spies CM; Straub RH; Cutolo M; Buttgereit F
    Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25608777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.